| 1 |
Gwenzi T, Zhu A, Schrotz-king P, Schöttker B, Hoffmeister M, Edelmann D, Brenner H. Prognostic value of post-operative inflammatory biomarkers in colorectal cancer patients: Systematic Review and Meta-Analysis.. [DOI: 10.21203/rs.3.rs-2701700/v1] [Reference Citation Analysis]
|
| 2 |
Tyagi N, Gupta P, Khan Z, Neupane YR, Mangla B, Mehra N, Ralli T, Alhalmi A, Ali A, Al Kamaly O, Saleh A, Nasr FA, Kohli K. Superparamagnetic Iron-Oxide Nanoparticles Synthesized via Green Chemistry for the Potential Treatment of Breast Cancer. Molecules 2023;28. [PMID: 36903587 DOI: 10.3390/molecules28052343] [Reference Citation Analysis]
|
| 3 |
Zhu L, Li Y, Jiang M, Ke C, Long H, Qiu M, Zhang L, Ye C, Zhou X, Jiang ZX, Chen S. Self-Assembly of Precisely Fluorinated Albumin for Dual Imaging-Guided Synergistic Chemo-Photothermal-Photodynamic Cancer Therapy. ACS Appl Mater Interfaces 2023;15:2665-78. [PMID: 36604154 DOI: 10.1021/acsami.2c19161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Chen J, Cong X. Surface-engineered nanoparticles in cancer immune response and immunotherapy: Current status and future prospects. Biomed Pharmacother 2023;157:113998. [PMID: 36399829 DOI: 10.1016/j.biopha.2022.113998] [Reference Citation Analysis]
|
| 5 |
Wang Y, Iqbal H, Ur-rehman U, Zhai L, Yuan Z, Razzaq A, Lv M, Wei H, Ning X, Xin J, Xiao R. Albumin-based nanodevices for breast cancer diagnosis and therapy. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.104072] [Reference Citation Analysis]
|
| 6 |
Petrov KD, Chubarov AS. Magnetite Nanoparticles for Biomedical Applications. Encyclopedia 2022;2:1811-1828. [DOI: 10.3390/encyclopedia2040125] [Reference Citation Analysis]
|
| 7 |
Liu S, Li L, Zhang X, Meng Q. Nanotherapies from an oncologist doctor's view. Smart Materials in Medicine 2022. [DOI: 10.1016/j.smaim.2022.07.005] [Reference Citation Analysis]
|
| 8 |
Estifeeva TM, Barmin RA, Rudakovskaya PG, Nechaeva AM, Luss AL, Mezhuev YO, Chernyshev VS, Krivoborodov EG, Klimenko OA, Sindeeva OA, Demina PA, Petrov KS, Chuprov-Netochin RN, Fedotkina EP, Korotchenko OE, Sencha EA, Sencha AN, Shtilman MI, Gorin DA. Hybrid (Bovine Serum Albumin)/Poly(N-vinyl-2-pyrrolidone-co-acrylic acid)-Shelled Microbubbles as Advanced Ultrasound Contrast Agents. ACS Appl Bio Mater 2022. [PMID: 35791763 DOI: 10.1021/acsabm.2c00331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Neganova ME, Aleksandrova YR, Sukocheva OA, Klochkov SG. Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Semin Cancer Biol 2022:S1044-579X(22)00155-9. [PMID: 35779712 DOI: 10.1016/j.semcancer.2022.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Sinai Kunde S, Wairkar S. Folic acid anchored urchin-like raloxifene nanoparticles for receptor targeting in breast cancer: Synthesis, optimisation and in vitro biological evaluation. Int J Pharm 2022;623:121926. [PMID: 35716974 DOI: 10.1016/j.ijpharm.2022.121926] [Reference Citation Analysis]
|
| 11 |
Sukocheva OA, Liu J, Neganova ME, Beeraka NM, Aleksandrova YR, Manogaran P, Grigorevskikh EM, Chubarev VN, Fan R. Perspectives of using microRNA-loaded nanocarriers for epigenetic reprogramming of drug resistant colorectal cancers. Semin Cancer Biol 2022:S1044-579X(22)00123-7. [PMID: 35623562 DOI: 10.1016/j.semcancer.2022.05.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Karami K, Mehvari F, Ramezanzade V, Zakariazadeh M, Kharaziha M, Ramezanpour A. The interaction studies of novel imine ligands and palladium(II) complexes with DNA and BSA for drug delivery application: the anti-cancer activity and molecular docking evaluation. Journal of Molecular Liquids 2022. [DOI: 10.1016/j.molliq.2022.119493] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 13 |
Kunde SS, Wairkar S. Targeted delivery of albumin nanoparticles for breast cancer: A review. Colloids Surf B Biointerfaces 2022;213:112422. [PMID: 35231688 DOI: 10.1016/j.colsurfb.2022.112422] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Ghaidaa S. Hameed, Methaq Hamad Sabar. Nano-carriers as a Selective Treatment for Cancer. AJPS 2022;21:55-66. [DOI: 10.32947/ajps.v21i1.802] [Reference Citation Analysis]
|
| 15 |
Yu XT, Sui SY, He YX, Yu CH, Peng Q. Nanomaterials-based photosensitizers and delivery systems for photodynamic cancer therapy. Biomater Adv 2022;135:212725. [PMID: 35929205 DOI: 10.1016/j.bioadv.2022.212725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Chubarov AS. Serum Albumin for Magnetic Nanoparticles Coating. Magnetochemistry 2022;8:13. [DOI: 10.3390/magnetochemistry8020013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 17 |
Cheng Z, Huang Y, Shao P, Wang L, Zhu S, Yu J, Lu W. Hypoxia-Activated Albumin-Binding Exatecan Prodrug for Cancer Therapy. ACS Omega 2022;7:1082-9. [PMID: 35036771 DOI: 10.1021/acsomega.1c05671] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Miao Y, Yang T, Yang S, Yang M, Mao C. Protein nanoparticles directed cancer imaging and therapy. Nano Converg 2022;9:2. [PMID: 34997888 DOI: 10.1186/s40580-021-00293-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Zhu S, Cheng Z, Hu Y, Chen Z, Zhang J, Ke C, Yang Q, Lin F, Chen Y, Wang J. Prognostic Value of the Systemic Immune-Inflammation Index and Prognostic Nutritional Index in Patients With Medulloblastoma Undergoing Surgical Resection. Front Nutr 2021;8:754958. [PMID: 34977115 DOI: 10.3389/fnut.2021.754958] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Bukhari B, Naveed M, Makhdoom SI, Jabeen K, Asif MF, Batool H, Ahmed N, Chan YY. A Comparison Between Organic and Inorganic Nanoparticles: Prime Nanoparticles for Tumor Curation. NANO 2021;16:2130011. [DOI: 10.1142/s1793292021300115] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 21 |
Shen X, Liu X, Li T, Chen Y, Chen Y, Wang P, Zheng L, Yang H, Wu C, Deng S, Liu Y. Recent Advancements in Serum Albumin-Based Nanovehicles Toward Potential Cancer Diagnosis and Therapy. Front Chem 2021;9:746646. [PMID: 34869202 DOI: 10.3389/fchem.2021.746646] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Tan T, Yang Q, Chen D, Zhao J, Xiang L, Feng J, Song X, Fu Y, Gong T. Chondroitin sulfate-mediated albumin corona nanoparticles for the treatment of breast cancer. Asian J Pharm Sci 2021;16:508-18. [PMID: 34703499 DOI: 10.1016/j.ajps.2021.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 23 |
Cheng WT, Ho HO, Lin SY, Liu DZ, Chen LC, Sheu MT. Carfilzomib and Paclitaxel Co-Loaded Protein Nanoparticles an Effective Therapy Against Pancreatic Adenocarcinomas. Int J Nanomedicine 2021;16:6825-41. [PMID: 34675510 DOI: 10.2147/IJN.S331210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 24 |
Gao Y, Yue Y, Xiong S. An Albumin-Binding Domain Peptide Confers Enhanced Immunoprotection Against Viral Myocarditis by CVB3 VP1 Vaccine. Front Immunol 2021;12:666594. [PMID: 34630378 DOI: 10.3389/fimmu.2021.666594] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 25 |
Zhang Y, Cui H, Zhang R, Zhang H, Huang W. Nanoparticulation of Prodrug into Medicines for Cancer Therapy. Adv Sci (Weinh) 2021;8:e2101454. [PMID: 34323373 DOI: 10.1002/advs.202101454] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
|
| 26 |
Gülsu A, Aslanpay MC. Albumin nanoparticles for use in cancer drug delivery. Emerging Materials Research 2021;10:321-8. [DOI: 10.1680/jemmr.21.00035] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 27 |
Ortelli S, Costa AL, Zanoni I, Blosi M, Geiss O, Bianchi I, Mehn D, Fumagalli F, Ceccone G, Guerrini G, Calzolai L. TiO2@BSA nano-composites investigated through orthogonal multi-techniques characterization platform. Colloids Surf B Biointerfaces 2021;207:112037. [PMID: 34416445 DOI: 10.1016/j.colsurfb.2021.112037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 28 |
Ramos-membrive R, Erhard Á, Luis de Redín I, Quincoces G, Collantes M, Ecay M, Irache JM, Peñuelas I. In vivo SPECT-CT imaging and characterization of technetium-99m-labeled bevacizumab-loaded human serum albumin pegylated nanoparticles. Journal of Drug Delivery Science and Technology 2021;64:101809. [DOI: 10.1016/j.jddst.2020.101809] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Tao HY, Wang RQ, Sheng WJ, Zhen YS. The development of human serum albumin-based drugs and relevant fusion proteins for cancer therapy. Int J Biol Macromol 2021;187:24-34. [PMID: 34284054 DOI: 10.1016/j.ijbiomac.2021.07.080] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 30 |
Kozieł SA, Lesiów MK, Wojtala D, Dyguda-Kazimierowicz E, Bieńko D, Komarnicka UK. Interaction between DNA, Albumin and Apo-Transferrin and Iridium(III) Complexes with Phosphines Derived from Fluoroquinolones as a Potent Anticancer Drug. Pharmaceuticals (Basel) 2021;14:685. [PMID: 34358111 DOI: 10.3390/ph14070685] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 31 |
Li H, Wang Y, Tang Q, Yin D, Tang C, He E, Zou L, Peng Q. The protein corona and its effects on nanoparticle-based drug delivery systems. Acta Biomater 2021;129:57-72. [PMID: 34048973 DOI: 10.1016/j.actbio.2021.05.019] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 25.5] [Reference Citation Analysis]
|
| 32 |
Prajapati R, Somoza Á. Albumin Nanostructures for Nucleic Acid Delivery in Cancer: Current Trend, Emerging Issues, and Possible Solutions. Cancers (Basel) 2021;13:3454. [PMID: 34298666 DOI: 10.3390/cancers13143454] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 33 |
Xie J, Wang Y, Choi W, Jangili P, Ge Y, Xu Y, Kang J, Liu L, Zhang B, Xie Z, He J, Xie N, Nie G, Zhang H, Kim JS. Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies. Chem Soc Rev 2021;50:9152-201. [PMID: 34223847 DOI: 10.1039/d0cs01370f] [Cited by in Crossref: 70] [Cited by in F6Publishing: 90] [Article Influence: 35.0] [Reference Citation Analysis]
|
| 34 |
Yasaswi PS, Shetty K, Yadav KS. Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. J Control Release 2021;336:549-71. [PMID: 34229001 DOI: 10.1016/j.jconrel.2021.07.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 35 |
Lee J, Hlaing SP, Hasan N, Kwak D, Kim H, Cao J, Yoon IS, Yun H, Jung Y, Yoo JW. Tumor-Penetrable Nitric Oxide-Releasing Nanoparticles Potentiate Local Antimelanoma Therapy. ACS Appl Mater Interfaces 2021;13:30383-96. [PMID: 34162207 DOI: 10.1021/acsami.1c07407] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 36 |
Zhang Q, Zhang J, Song J, Liu Y, Ren X, Zhao Y. Protein-Based Nanomedicine for Therapeutic Benefits of Cancer. ACS Nano 2021;15:8001-38. [PMID: 33900074 DOI: 10.1021/acsnano.1c00476] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 37 |
Taguchi K, Okamoto Y, Matsumoto K, Otagiri M, Chuang VTG. When Albumin Meets Liposomes: A Feasible Drug Carrier for Biomedical Applications. Pharmaceuticals (Basel) 2021;14:296. [PMID: 33810483 DOI: 10.3390/ph14040296] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 38 |
Wang Z, Chen M, Liu JJ, Chen RH, Yu Q, Wang GM, Nie LM, Huang WH, Zhang GJ. Human Serum Albumin Decorated Indocyanine Green Improves Fluorescence-Guided Resection of Residual Lesions of Breast Cancer in Mice. Front Oncol 2021;11:614050. [PMID: 33763353 DOI: 10.3389/fonc.2021.614050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 39 |
Lei C, Liu X, Chen Q, Li Y, Zhou J, Zhou L, Zou T. Hyaluronic acid and albumin based nanoparticles for drug delivery. Journal of Controlled Release 2021;331:416-33. [DOI: 10.1016/j.jconrel.2021.01.033] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
|
| 40 |
Zare I, Chevrier DM, Cifuentes-rius A, Moradi N, Xianyu Y, Ghosh S, Trapiella-alfonso L, Tian Y, Shourangiz-haghighi A, Mukherjee S, Fan K, Hamblin MR. Protein-protected metal nanoclusters as diagnostic and therapeutic platforms for biomedical applications. Materials Today 2021. [DOI: 10.1016/j.mattod.2020.10.027] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 41 |
Wang D, Li H, Chen W, Yang H, Liu Y, You B, Zhang X. Efficient tumor-targeting delivery of siRNA via folate-receptor mediated biomimetic albumin nanoparticles enhanced by all-trans retinoic acid. Materials Science and Engineering: C 2021;119:111583. [DOI: 10.1016/j.msec.2020.111583] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 42 |
Kudarha RR, Sawant KK. Hyaluronic acid conjugated albumin nanoparticles for efficient receptor mediated brain targeted delivery of temozolomide. Journal of Drug Delivery Science and Technology 2021;61:102129. [DOI: 10.1016/j.jddst.2020.102129] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 43 |
Ahmad A, Mubarak N, Naseem K, Tabassum H, Rizwan M, Najda A, Kashif M, Bin-jumah M, Hussain A, Shaheen A, Abdel-daim MM, Ali S, Hussain S. Recent advancement and development of chitin and chitosan-based nanocomposite for drug delivery: Critical approach to clinical research. Arabian Journal of Chemistry 2020;13:8935-64. [DOI: 10.1016/j.arabjc.2020.10.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 44 |
Iqbal H, Yang T, Li T, Zhang M, Ke H, Ding D, Deng Y, Chen H. Serum protein-based nanoparticles for cancer diagnosis and treatment. J Control Release 2021;329:997-1022. [PMID: 33091526 DOI: 10.1016/j.jconrel.2020.10.030] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 45 |
Kudarha RR, Sawant KK. Chondroitin sulfate conjugation facilitates tumor cell internalization of albumin nanoparticles for brain-targeted delivery of temozolomide via CD44 receptor-mediated targeting. Drug Deliv Transl Res 2020. [PMID: 33026610 DOI: 10.1007/s13346-020-00861-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 46 |
Tesarova B, Musilek K, Rex S, Heger Z. Taking advantage of cellular uptake of ferritin nanocages for targeted drug delivery. Journal of Controlled Release 2020;325:176-90. [DOI: 10.1016/j.jconrel.2020.06.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 47 |
Esim O, Gumustas M, Hascicek C, Ozkan SA. A novel stability-indicating analytical method development for simultaneous determination of carboplatin and decitabine from nanoparticles. J Sep Sci 2020;43:3491-8. [PMID: 32644279 DOI: 10.1002/jssc.202000320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 48 |
Yan L, Shen J, Wang J, Yang X, Dong S, Lu S. Nanoparticle-Based Drug Delivery System: A Patient-Friendly Chemotherapy for Oncology. Dose Response 2020;18:1559325820936161. [PMID: 32699536 DOI: 10.1177/1559325820936161] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 49 |
Russo Krauss I, Picariello A, Vitiello G, De Santis A, Koutsioubas A, Houston JE, Fragneto G, Paduano L. Interaction with Human Serum Proteins Reveals Biocompatibility of Phosphocholine-Functionalized SPIONs and Formation of Albumin-Decorated Nanoparticles. Langmuir 2020;36:8777-91. [PMID: 32575987 DOI: 10.1021/acs.langmuir.0c01083] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 50 |
de Oliveira TD, Plutín AM, Luna-Dulcey L, Castellano EE, Cominetti MR, Batista AA. Cytotoxicity of ruthenium-N,N-disubstituted-N'-acylthioureas complexes. Mater Sci Eng C Mater Biol Appl 2020;115:111106. [PMID: 32600709 DOI: 10.1016/j.msec.2020.111106] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 51 |
Maviah MBJ, Farooq MA, Mavlyanova R, Veroniaina H, Filli MS, Aquib M, Kesse S, Boakye-Yiadom KO, Wang B. Food Protein-Based Nanodelivery Systems for Hydrophobic and Poorly Soluble Compounds. AAPS PharmSciTech 2020;21:101. [PMID: 32152890 DOI: 10.1208/s12249-020-01641-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 52 |
Liang K, Chen H. Protein-based nanoplatforms for tumor imaging and therapy. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1616. [PMID: 31999083 DOI: 10.1002/wnan.1616] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 53 |
Farooq MA, Aquib M, Farooq A, Haleem Khan D, Joelle Maviah MB, Sied Filli M, Kesse S, Boakye-Yiadom KO, Mavlyanova R, Parveen A, Wang B. Recent progress in nanotechnology-based novel drug delivery systems in designing of cisplatin for cancer therapy: an overview. Artif Cells Nanomed Biotechnol 2019;47:1674-92. [PMID: 31066300 DOI: 10.1080/21691401.2019.1604535] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 54 |
Bolaños K, Kogan MJ, Araya E. Capping gold nanoparticles with albumin to improve their biomedical properties. Int J Nanomedicine 2019;14:6387-406. [PMID: 31496693 DOI: 10.2147/IJN.S210992] [Cited by in Crossref: 74] [Cited by in F6Publishing: 78] [Article Influence: 18.5] [Reference Citation Analysis]
|
| 55 |
Roguin LP, Chiarante N, García Vior MC, Marino J. Zinc(II) phthalocyanines as photosensitizers for antitumor photodynamic therapy. Int J Biochem Cell Biol 2019;114:105575. [PMID: 31362060 DOI: 10.1016/j.biocel.2019.105575] [Cited by in Crossref: 62] [Cited by in F6Publishing: 65] [Article Influence: 15.5] [Reference Citation Analysis]
|
| 56 |
Xuan Q, Yang Y, Ji H, Tang S, Zhao J, Shao J, Wang J. Combination of the preoperative albumin to globulin ratio and neutrophil to lymphocyte ratio as a novel prognostic factor in patients with triple negative breast cancer. Cancer Manag Res 2019;11:5125-31. [PMID: 31213922 DOI: 10.2147/CMAR.S195324] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 57 |
Kloypan C, Suwannasom N, Chaiwaree S, Prapan A, Smuda K, Baisaeng N, Pruß A, Georgieva R, Bäumler H. In-vitro haemocompatibility of dextran-protein submicron particles. Artif Cells Nanomed Biotechnol 2019;47:241-9. [PMID: 30663396 DOI: 10.1080/21691401.2018.1548476] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 58 |
Li C, Dai J, Zheng D, Zhao J, Tao Y, Lei J, Xi X, Liu J. An efficient prodrug-based nanoscale delivery platform constructed by water soluble eight-arm-polyethylene glycol-diosgenin conjugate. Materials Science and Engineering: C 2019;98:153-60. [DOI: 10.1016/j.msec.2018.12.078] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 59 |
Park JE, Park J, Jun Y, Oh Y, Ryoo G, Jeong YS, Gadalla HH, Min JS, Jo JH, Song MG, Kang KW, Bae SK, Yeo Y, Lee W. Expanding therapeutic utility of carfilzomib for breast cancer therapy by novel albumin-coated nanocrystal formulation. J Control Release 2019;302:148-59. [PMID: 30954620 DOI: 10.1016/j.jconrel.2019.04.006] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 60 |
Liu R, Zhang H, Zhang F, Wang X, Liu X, Zhang Y. Polydopamine doped reduced graphene oxide/mesoporous silica nanosheets for chemo-photothermal and enhanced photothermal therapy. Materials Science and Engineering: C 2019;96:138-45. [DOI: 10.1016/j.msec.2018.10.093] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 9.8] [Reference Citation Analysis]
|
| 61 |
Razi MA, Wakabayashi R, Goto M, Kamiya N. Self-Assembled Reduced Albumin and Glycol Chitosan Nanoparticles for Paclitaxel Delivery. Langmuir 2019;35:2610-8. [PMID: 30673276 DOI: 10.1021/acs.langmuir.8b02809] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 62 |
Tao C, Chuah YJ, Xu C, Wang DA. Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications. J Mater Chem B 2019;7:357-67. [PMID: 32254722 DOI: 10.1039/c8tb02477d] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 63 |
Yokoi T, Ishii K. Dependence of phthalocyanine-based fluorescence on albumin structure: A fluorescent probe for ascorbic acid. Journal of Photochemistry and Photobiology A: Chemistry 2018;364:1-5. [DOI: 10.1016/j.jphotochem.2018.05.036] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 64 |
Diaconu A, Nita LE, Chiriac AP, Butnaru M. Investigation of the magnetic field effect upon interpolymeric complexes formation based on bovine serum albumin and poly(aspartic acid). Int J Biol Macromol 2018;119:974-81. [PMID: 30098364 DOI: 10.1016/j.ijbiomac.2018.08.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 65 |
Matos MJ. Learning from nature: the role of albumin in drug delivery. Future Medicinal Chemistry 2018;10:983-5. [DOI: 10.4155/fmc-2018-0053] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 66 |
Lv W, Shen Y, Yang H, Yang R, Cai W, Zhang J, Yuan L, Duan Y, Zhang L. A Novel Bimodal Imaging Agent Targeting HER2 Molecule of Breast Cancer. J Immunol Res 2018;2018:6202876. [PMID: 29854844 DOI: 10.1155/2018/6202876] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 67 |
Gomes AT, Neves MG, Cavaleiro JA. Cancer, Photodynamic Therapy and Porphyrin-Type Derivatives. An Acad Bras Ciênc 2018;90:993-1026. [DOI: 10.1590/0001-3765201820170811] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 15.6] [Reference Citation Analysis]
|
| 68 |
Liu T, Chen S, Zhang S, Wu X, Wu P, Miao B, Cai X. Transferrin-functionalized chitosan- graft -poly( l -lysine) dendrons as a high-efficiency gene delivery carrier for nasopharyngeal carcinoma therapy. J Mater Chem B 2018;6:4314-25. [DOI: 10.1039/c8tb00489g] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
|
